Lisata Therapeutics, Inc. (LSTA)
NASDAQ·Healthcare·Biotechnology
$3.55
+1.99%
Mkt Cap $44.46M
No analyst coverage available
We don't have analyst ratings or price target data for Lisata Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.